ARCHIVES

FDA Selects 23 Survivors To Review Drug Applications.

This article is from The Cancer Letter archive.

Vol. 27 No. 24 | June 15, 2001

Download PDF Visit The Full Archive

Related Articles

House panel examines use of grant funds.

September 23, 2005

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

December 5, 1986

House Plan Promises $3.5 Billion For NIH; Cooperative Groups May Get AHRQ Funds

January 23, 2009

Thompson Tours Brown’s Brain Science Center.

March 16, 2001

FDA Advisors Give Dox-SL Conditional Approval; Ok Zoladex

February 24, 1995

PHS Revises Lab Animal Policies

May 10, 1985